cbdMD Inc (YCBD)
0.7588
-0.04
(-5.50%)
USD |
NYAM |
May 08, 16:00
0.7588
0.00 (0.00%)
After-Hours: 18:47
cbdMD Profit Margin (Quarterly): -18.54% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.54% |
| September 30, 2023 | -278.0% |
| June 30, 2023 | -28.93% |
| March 31, 2023 | -21.42% |
| December 31, 2022 | -65.01% |
| September 30, 2022 | -186.1% |
| June 30, 2022 | -368.1% |
| March 31, 2022 | -48.37% |
| December 31, 2021 | -205.5% |
| September 30, 2021 | -30.90% |
| June 30, 2021 | 14.56% |
| March 31, 2021 | -106.0% |
| December 31, 2020 | -76.21% |
| September 30, 2020 | -53.49% |
| June 30, 2020 | -84.17% |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -346.0% |
| March 31, 2019 | -564.0% |
| December 31, 2018 | -453.1% |
| September 30, 2018 | 13.67% |
| June 30, 2018 | 6.44% |
| March 31, 2018 | 45.58% |
| December 31, 2017 | -164.7% |
| September 30, 2017 | -31.34% |
| June 30, 2017 | -11.79% |
| March 31, 2017 | -39.42% |
| December 31, 2016 | -317.5% |
| September 30, 2016 | -448.2% |
| June 30, 2016 | -313.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-368.1%
Minimum
Jun 2022
14.56%
Maximum
Jun 2021
-118.9%
Average
-70.61%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -106.1% |
| Return on Assets | -74.73% |
| Return on Invested Capital | -106.0% |
| Gross Profit Margin (Quarterly) | 66.18% |
| Operating Margin (Quarterly) | -19.83% |
| Return on Net Operating Assets | -92.21% |